Xtant Medical Holdings, Inc. (XTNT) stock
Close on Nov 10, 2026Market cap $37.88MP/E –Yield –
Xtant Medical Holdings, Inc. saw revenue fall 14.3% to $109.53M over the twelve months to Jun 30, 2026. Operating income fell 37582.1% to -$10.50M, moving the operating margin from 0.0% to -9.6%. Free cash flow was -$696.00K. At the latest close the market valued the company at $37.88M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $37.88M
- P/E ratio
- –
- Price to sales
- 0.35
- Price to book
- 0.95
- Dividend yield
- –
- Free cash flow yield
- -1.84%
Fundamentals
- Revenue
- $109.53M
- Net income
- -$11.14M
- EPS, diluted
- -$0.08
- Free cash flow
- -$696.00K
- Book value per share
- $0.29
- Diluted shares
- 140M
Trading
- Next earnings
- Q3 FY2026, expected soon
- Previous close
- $0.28
- Open
- $0.29
- Day's range
- $0.27 – $0.29
- Volume
- 662,827
- Average volume (20 days)
- 147,157
- Beta (5 years)
- 0.60
- 52-week range
- $0.27 – $0.84
- RSI (14 days)
- 35.2
- Volatility (1 year)
- 63.0%
- Relative volume
- 0.54×
- WACC
- 8.8%
Market cap history
Month-end market cap since 2011, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 10, 2026. The S&P 500 is measured by the SPY fund.
| Period | XTNT | S&P 500 | Difference | XTNT per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -17.2% | -3.7% | −13.5 pts | ||
| 3 months | -39.5% | -2.7% | −36.7 pts | ||
| Year to date | -65.6% | +10.8% | −76.4 pts | ||
| 1 year | -64.5% | +11.2% | −75.8 pts | ||
| 3 years | -76.9% | +76.5% | −153.4 pts | -38.7% | +20.8% |
| 5 years | -75.9% | +72.9% | −148.8 pts | -24.8% | +11.6% |
| 10 years | -96.2% | +304.8% | −401.0 pts | -27.9% | +15.0% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Xtant Medical filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Update
- Results
- Update
- Update
About Xtant Medical
Surgical & Medical Instruments & Apparatus
Xtant Medical Holdings, Inc. develops, manufactures, and markets orthobiologics and spinal implant fixation systems designed to facilitate spinal fusion in degenerative, deformity, and complex spine surgeries. Its orthobiologics offerings include demineralized bone matrices, viable bone allografts, synthetic bone grafts, amniotic membranes, and surgical collagen powders used in spine, trauma, foot and ankle, sports medicine, joint, and wound care applications. Its spinal implant line comprises cervical plating systems, occipito-cervico-thoracic hardware, thoracolumbar pedicle screw systems, sacroiliac joint fusion devices, and interbody spacers made from titanium and PEEK materials. The company supplies these solutions to orthopedic spine surgeons and neurosurgeons.
Company profile, executives and historyXtant Medical stock: common questions
What is Xtant Medical's stock price?
XTNT closed at $0.27 on Nov 10, 2026, down 3.57% on the day. Over the past 52 weeks it traded between $0.27 and $0.84.
What is Xtant Medical's market cap?
Xtant Medical was worth $37.88M at the close on Nov 10, 2026: the share price times the diluted shares outstanding.
What is XTNT's P/E ratio?
Xtant Medical lost money over the twelve months to Jun 30, 2026 (diluted EPS -$0.08), so it has no meaningful P/E ratio.
How much revenue does Xtant Medical make?
Xtant Medical reported revenue of $109.53M for the twelve months to Jun 30, 2026, down 14.3% from a year earlier.
Does Xtant Medical pay a dividend?
No. Xtant Medical has not paid a cash dividend over the last twelve months.
When does Xtant Medical report earnings next?
Xtant Medical's Q3 FY2026 results are due soon; the company has not yet filed them with the SEC.
How has XTNT stock performed over the past year?
Including dividends, XTNT returned -64.5% over the past year, against +11.2% for the S&P 500.
Who are Xtant Medical's competitors?
Companies most similar to Xtant Medical by business, industry and size include SIBN, TELA, ANIK, CARL, IRMD.
See a number that looks wrong?